228 related articles for article (PubMed ID: 402246)
21. Combined diphosphonate and calcitonin therapy for Paget's disease of bone.
Hosking DJ; Bijvoet OL
Calcif Tissue Res; 1976 Aug; 21 Suppl():321-6. PubMed ID: 821599
[No Abstract] [Full Text] [Related]
22. Mithramycin therapy in Paget's disease.
Russell AS; Lentle BC
Can Med Assoc J; 1974 Feb; 110(4):397-400. PubMed ID: 4273095
[TBL] [Abstract][Full Text] [Related]
23. Long-term biochemical response after bisphosphonate therapy in Paget's disease of bone. Proposed intervals for monitoring treatment.
Alvarez L; Peris P; Guañabens N; Vidal S; Quintó L; Monegal A; Pons F; Ballesta AM; Muñoz-Gómez J
Rheumatology (Oxford); 2004 Jul; 43(7):869-74. PubMed ID: 15054158
[TBL] [Abstract][Full Text] [Related]
24. Biochemical response to combination of disodium etidronate with calcitonin in Paget's disease.
O'Donoghue DJ; Hosking DJ
Bone; 1987; 8(4):219-25. PubMed ID: 3128315
[TBL] [Abstract][Full Text] [Related]
25. [Clinical, biological and histological effects of ethane-1-hydroxy 1, 1-diphosphonate (EDHP) in Paget's disease].
Meunier P; Chapuy MC; Courpron P; Vignon E; Edouard C; Bernard J
Rev Rhum Mal Osteoartic; 1975 Nov; 42(11):699-705. PubMed ID: 817385
[TBL] [Abstract][Full Text] [Related]
26. Vitamin D in Paget's disease of bone.
Foldes J; Shamir S; Kidroni G; Menczel J
Clin Orthop Relat Res; 1989 Jun; (243):275-9. PubMed ID: 2498022
[TBL] [Abstract][Full Text] [Related]
27. Treatment of Paget's disease of bone with ethane-1, hydroxy-1,1 diphosphonate (EHDP) at a low dosage (5 mg/kg/day).
Alexandre CM; Chapuy MC; Vignon E; Edouard C; Johnston CC; Meunier PJ
Clin Orthop Relat Res; 1983 Apr; (174):193-205. PubMed ID: 6403270
[TBL] [Abstract][Full Text] [Related]
28. Long-term therapy of Paget's disease of bone with EHDP.
Siris ES; Canfield RE; Jacobs TP; Baquiran DC
Arthritis Rheum; 1980 Oct; 23(10):1177-84. PubMed ID: 6775644
[TBL] [Abstract][Full Text] [Related]
29. Diphosphonate therapy of paget's disease of bone.
Canfield R; Rosner W; Skinner J; McWhorter J; Resnick L; Feldman F; Kammerman S; Ryan K; Kunigonis M; Bohne W
J Clin Endocrinol Metab; 1977 Jan; 44(1):96-106. PubMed ID: 401827
[TBL] [Abstract][Full Text] [Related]
30. [The long-term results of ethanehydroxydiphosphonate treatment in Paget's disease of bone].
Morales Piga A; Corres González J; Pérez Ruiz F
Rev Clin Esp; 1991 Oct; 189(5):213-7. PubMed ID: 1801068
[TBL] [Abstract][Full Text] [Related]
31. Successful treatment of resistant Paget's disease of bone with pamidronate.
Mallette LE
Arch Intern Med; 1989 Dec; 149(12):2765-7. PubMed ID: 2596945
[TBL] [Abstract][Full Text] [Related]
32. [Combined treatment of Paget's disease of bone with calcitonin and the diphosphonate EHDP].
Jaeger P; Bischoff-Delaloye A; Burckhardt P
Schweiz Med Wochenschr; 1981 Dec; 111(49):1893-7. PubMed ID: 6800028
[TBL] [Abstract][Full Text] [Related]
33. Use of etidronate (EHDP) in Paget's disease of bone.
Johnston CC; Khairi MR; Meunier PJ
Arthritis Rheum; 1980 Oct; 23(10):1172-6. PubMed ID: 6775643
[TBL] [Abstract][Full Text] [Related]
34. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
Abelson A
Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
[TBL] [Abstract][Full Text] [Related]
35. Synthetic human calcitonin in refractory Paget's disease of bone.
Altman RD; Collins-Yudiskas B
Arch Intern Med; 1987 Jul; 147(7):1305-8. PubMed ID: 3111398
[TBL] [Abstract][Full Text] [Related]
36. The treatment of Paget's bone disease with sodium ethidronate.
Fromm GA; Schajowicz F; Casco C; Ghiringhelli G; Mautalen CA
Am J Med Sci; 1979; 277(1):29-37. PubMed ID: 106728
[TBL] [Abstract][Full Text] [Related]
37. Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone.
Siris E; Weinstein RS; Altman R; Conte JM; Favus M; Lombardi A; Lyles K; McIlwain H; Murphy WA; Reda C; Rude R; Seton M; Tiegs R; Thompson D; Tucci JR; Yates AJ; Zimering M
J Clin Endocrinol Metab; 1996 Mar; 81(3):961-7. PubMed ID: 8772558
[TBL] [Abstract][Full Text] [Related]
38. Bone tissue in Paget's disease treated by ethane-1, hydroxy-1, 1 diphosphonate (EHDP). Structure, ultrastructure, and immunocytology.
Basle MF; Rebel A; Renier JC; Audran M; Filmon R; Malkani K
Clin Orthop Relat Res; 1984 Apr; (184):281-8. PubMed ID: 6423333
[TBL] [Abstract][Full Text] [Related]
39. [EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of polyosseous Paget disease].
Kovarik J; Niebauer B; Woloszczuk W; Frühwald F; Kolbe H
Wien Klin Wochenschr; 1985 Mar; 97(7):311-5. PubMed ID: 3922124
[TBL] [Abstract][Full Text] [Related]
40. Efficacious management with aminobisphosphonate (APD) in Paget's disease of bone.
Harinck HI; Bijvoet OL; Blanksma HJ; Dahlinghaus-Nienhuys PJ
Clin Orthop Relat Res; 1987 Apr; (217):79-98. PubMed ID: 2951049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
